Can heart arrhythmia be diagnosed in time? A healthtech company has the answer.
Join Codrin Arsene and Stuart Long, CEO @ Infobionic, a healthtech company that recently secured $50 Million in Financing to Support Continued Growth of the MoMe® Kardia System for Cardiac Arrhythmia Detection. MoMe® is an Apple mouse-like smart heart monitor which gives doctors and patients 24/7 access to ECG data collected on the go. The MoMe® device uses Artificial Intelligence to interpret massive amounts of data and provide actionable insights to physicians in order to improve the quality of care for patients all over the world. The MoMe remote cardiac monitoring platform was granted 501(k) clearance from the U.S. Food and Drug Administration in 2015. Learn: How MoMe works Why a remote afib device is the future of cardiac care Who can benefit from it